Nesa Medtech

🚀 🚀 Huge Milestone ✅ Nesa Medtech flagship product GYIDE has received CDSCO clearance (Indian Regulatory). GYIDE received the clearance under the Class C category, which is one of the highest-risk classifications. #womenshealth #medtech #innovation #healthcare

Nesa Medtech's FMRA Application results were presented by Dr. Yogitha P at the prestigious Global Conference on Gynaecological Ultrasound (GynoUS), where Nesa Medtech was awarded the second prize for their outstanding oral presentation. The key aspect was the comparison of FMRA in mapping and measuring uterine fibroids with the gold standard MRI. #womenshealth #womenshealthmatters #gynecology #innovation #femtech #medtech

Exciting news!!!!! Nesa Medtech is one of the top seven startups for the OB/GYN Innovation award by Femtech World #womenshealth #womenshealthmatters #gynecology #innovation #femtech #medtech https://lnkd.in/eexFRKPe?

Let's take a moment to appreciate the women in our lives on #internationalwomensday At Nesa Medtech, we are committed to transforming #womenshealth

Nesa Medtech is attending Arab Health Exhibition to meet potential suppliers and manufacturers. Also looking forward to catch up on the latest innovations in #medicaldevices . Catchup with Nesa team VINEESHKUMAR VISHWAKARMA and Sanjay G at #arabhealth2024.

Our CEO Sreekar Kothamachu is attending J P Morgan Health Care Conference "24 to meet investors and potential partners and share our latest accomplishments. #medicaldevices #JPM24 #womenshealth #medtechinnovation

2023 was really great and best so far in our journey !! Our team Nesa Medtech has achieved some amazing milestones. We are extremely proud of them. A few highlights: - Received our first 510(k) clearance from US FDA. - Closed Pre-Series A round - Multiple Patents Granted - OnBoarded Industry Experts - KickStarted Clinical Adoption Studies Excited to welcome 2024 and the incredible milestones we are set to realise in our mission of transforming womens health. #womenshealth #medtechinnovation

Amazing week at MedTech Strategist #InnovationSF23 Discussions covered the latest updates in regulations, reimbursements, and strategic & investors perspective of market. Best was catching up with amazing fellow medtech founders and routing for startups at MedTech Innovator pitch event. Giovanni Lauricella Paul Grand David Uffer

Just wrapped up an incredible experience at # AAGL2023 . Our CEO Sreekar Kothamachu and Advisor Richard Stark had incredible meetings with industry partners and also discussions with MIGS clinicians on how Nesa Medtech technology can potentially transform #womenshealth

The rise of FemTech holds immense significance, poised to reshape the landscape of women's and global healthcare. With the rapid evolution in products and services, there's a remarkable push to tailor technological progress to address diverse aspects like reproductive health, menstrual care, #maternal well-being, and menopause. Recent advancements include Movano Health's submission of a 510(k) premarket notification to the FDA for the Evie Ring, marking a pivotal step in its review process. Nesa Medtech, an Indian femtech company, secured the FDA's 510(k) clearance for its Fibroid Mapping Reviewer Application (FMRA). This breakthrough tool utilizes ultrasound images to create a 3D model of the uterus, aiding diagnosis and treatment planning for symptomatic uterine fibroids. These innovations bridge knowledge and care gaps, offering precise solutions to women's healthcare needs. #FemTech is helping usher in an era of personalized and inclusive #healthcare, elevating women's well-being across all life stages.